CREDIT SUISSE AG/ - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q4 2021$317,000
-42.7%
59,172
-33.4%
0.00%
Q3 2021$553,000
+137.3%
88,829
+130.0%
0.00%
Q2 2021$233,000
-29.0%
38,623
+15.6%
0.00%
Q1 2021$328,00033,4230.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 932,200$4,792,0000.21%
Ikarian Capital, LLC 77,650$399,0000.05%
Gradient Capital Advisors, LLC 20,000$103,0000.04%
Belvedere Trading LLC 37,100$209,0000.01%
WEST PACES ADVISORS INC. 1,665$8,5580.00%
OSAIC HOLDINGS, INC. 20$00.00%
DIMENSIONAL FUND ADVISORS LP 13,113$67,0000.00%
BANK OF AMERICA CORP /DE/ 57,517$295,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3,466$18,0000.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders